Genentech, Abbott team up
From Times Wire Services
Abbott Laboratories Inc. and Genentech Inc. will collaborate to develop and eventually sell two Abbott cancer drugs now in early stages of human testing, the companies said.
The drug makers did not disclose financial terms of the global deal, under which they will work together on all aspects of further development of the drugs discovered by Abbott, known as ABT-263 and ABT-869.
They will co-promote the drugs in the U.S., with Abbott marketing them overseas.
